Modern Medicine News

2017 Physician Writing Contest winners - Third PlaceAchieving work-life balance is easier said than done, but doctors have found solutions.
2017 Physician Writing Contest winners - Second PlaceAchieving work-life balance is easier said than done, but doctors have found solutions.
Why physicians should become active on social media
Why physicians should become active on social mediaIf you and your team haven’t discussed how social media can be used to grow your practice and get seen in a competitive market, I hope you keep reading. Finding success with social media takes time and energy, but it’s never too late to start building momentum.
What are facial blotting papers?One of the most widely used techniques for decreasing facial oil is the use of blotting papers, especially popular in East Asian nations
How does sebum interact with airborne pollution?One of the current appearance issues receiving attention in the popular press is the effect of air pollution on the skin.
Does dry shampoo work?Just as facial blotting papers are used to control facial sebum, dry shampoos are used to control scalp sebum.
Treating ROP: Laser associated with high success rate for retinopathy of prematurityLaser photocoagulation is a time-tested, well-defined, and effective treatment for retinopathy of prematurity (ROP) with requirements for follow-up that are much more manageable compared with anti-vascular endothelial growth factor (anti-VEGF) therapy, argued David K. Wallace, MD, MPH.
Treating ROP: Substantial benefits make anti-VEGF preferred for Zone I diseaseAnti-VEGF therapy for Zone I retinopathy of prematurity (ROP) is associated with better structural and functional outcomes than laser therapy, but also a longer recurrence risk period, said Helen A. Mintz-Hittner, MD.
Eye banks create the cycle of givingThe Human Tissue “box” that shows up at your hospital or surgery center and its contents go through quite a journey, which we in the eye banking world call the Cycle of Giving, to reach your destination.
Pipeline antibiotic omadacycline shows promise against MRSA and morePhase 3 data for Paratek Pharmaceuticals’ once-daily treatment with IV-to-oral omadacycline has shown the pipeline drug effectively and safely treats the most frequently isolated bacterial pathogens associated with skin infections, including methicillin-resistant Staphylococcus aureus (MRSA)